Systemic inflammation is associated with a reduction in Synaptopodin expression in the mouse hippocampus

Experimental Neurology

Volumn 261, Issue , 2014, Pages 230-235

  Strehl, Andreas ^a,b   Lenz, Maximilian ^a   Itsekson Hayosh, Zeev ^b   Becker, Denise ^a   Chapman, Joab ^b   Deller, Thomas ^a   Maggio, Nicola ^b,c   Vlachos, Andreas ^a  

^a GOETHE UNIVERSITY   (Germany)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Hebbian plasticity; Neuroinflammation; RTMS; Spine apparatus; Tumor necrosis factor alpha

Indexed keywords

SYNAPTOPODIN; TUMOR NECROSIS FACTOR ALPHA; ACTIN; ACTIN BINDING PROTEIN; CALCIUM; CHEMOKINE; CORTICOSTEROID; CYTOKINE; ESTROGEN RECEPTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; SYNPO PROTEIN, MOUSE;

ACTIN FILAMENT; ARTICLE; CALCIUM CELL LEVEL; COLLATERAL SULCUS; CONTROLLED STUDY; DOWN REGULATION; HIPPOCAMPUS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LONG TERM POTENTIATION; MOUSE; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA EXTRACTION; SIGNAL TRANSDUCTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; CYTOSKELETON; DENDRITIC SPINE; HIPPOCAMPAL CA1 REGION; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INFLAMMATION; MALE; MEMORY; SYNAPTIC TRANSMISSION; ACTION POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; ELECTROSTIMULATION; GENE EXPRESSION REGULATION; GENETICS; IN VITRO STUDY; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; TIME;

ACTION POTENTIALS; ANIMALS; CYTOKINES; ELECTRIC STIMULATION; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IN VITRO TECHNIQUES; INFLAMMATION; LIPOPOLYSACCHARIDES; LONG-TERM POTENTIATION; MALE; MICE; MICE, INBRED BALB C; MICROFILAMENT PROTEINS; NEURONS; RNA, MESSENGER; TIME FACTORS;

EID: 84905501650     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.04.033     Document Type: Article

References (64)

1. Allan S.M., Rothwell N.J. Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2001, 2:734-744.
2. Arnold S.E., Louneva N., Cao K., Wang L.S., Han L.Y., Wolk D.A., Negash S., Leurgans S.E., Schneider J.A., Buchman A.S., Wilson R.S., Bennett D.A. Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol. Aging 2013, 34:157-168.
3. Banks W.A., Robinson S.M. Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain Behav. Immun. 2010, 24:102-109.
4. Bas Orth C., Vlachos A., Del Turco D., Burbach G.J., Haas C.A., Mundel P., Feng G., Frotscher M., Deller T. Lamina-specific distribution of Synaptopodin, an actin-associated molecule essential for the spine apparatus, in identified principal cell dendrites of the mouse hippocampus. J. Comp. Neurol. 2005, 487:227-239.
5. Bas Orth C., Schultz C., Muller C.M., Frotscher M., Deller T. Loss of the cisternal organelle in the axon initial segment of cortical neurons in synaptopodin-deficient mice. J. Comp. Neurol. 2007, 504:441-449.
6. Becker D., Zahn N., Deller T., Vlachos A. Tumor necrosis factor alpha maintains denervation-induced homeostatic synaptic plasticity of mouse dentate granule cells. Front. Cell. Neurosci. 2013, 7:257.
7. Broussard G.J., Mytar J., Li R.C., Klapstein G.J. The role of inflammatory processes in Alzheimer's disease. Inflammopharmacology 2012, 20:109-126.
8. Butler M.P., O'Connor J.J., Moynagh P.N. Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP. Neuroscience 2004, 124:319-326.
9. Camacho-Arroyo I., Lopez-Griego L., Morales-Montor J. The role of cytokines in the regulation of neurotransmission. Neuroimmunomodulation 2009, 16:1-12.
10. Chapman T.R., Barrientos R.M., Ahrendsen J.T., Maier S.F., Patterson S.L. Synaptic correlates of increased cognitive vulnerability with aging: peripheral immune challenge and aging interact to disrupt theta-burst late-phase long-term potentiation in hippocampal area CA1. J. Neurosci. 2010, 30:7598-7603.
11. Counts S.E., Alldred M.J., Che S., Ginsberg S.D., Mufson E.J. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment. Neuropharmacology 2014, 79:172-179.
12. Cunningham A.J., Murray C.A., O'Neill L.A., Lynch M.A., O'Connor J.J. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci. Lett. 1996, 203:17-20.
13. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
14. Dayan E., Censor N., Buch E.R., Sandrini M., Cohen L.G. Noninvasive brain stimulation: from physiology to network dynamics and back. Nat. Neurosci. 2013, 16:838-844.
15. Deller T., Korte M., Chabanis S., Drakew A., Schwegler H., Stefani G.G., Zuniga A., Schwarz K., Bonhoeffer T., Zeller R., Frotscher M., Mundel P. Synaptopodin-deficient mice lack a spine apparatus and show deficits in synaptic plasticity. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:10494-10499.
16. Deller T., Bas Orth C., Del Turco D., Vlachos A., Burbach G.J., Drakew A., Chabanis S., Korte M., Schwegler H., Haas C.A., Frotscher M. A role for synaptopodin and the spine apparatus in hippocampal synaptic plasticity. Ann. Anat. 2007, 189:5-16.
17. Di Filippo M., Sarchielli P., Picconi B., Calabresi P. Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders. Trends Pharmacol. Sci. 2008, 29:402-412.
18. Di Filippo M., Chiasserini D., Gardoni F., Viviani B., Tozzi A., Giampa C., Costa C., Tantucci M., Zianni E., Boraso M., Siliquini S., de Iure A., Ghiglieri V., Colcelli E., Baker D., Sarchielli P., Fusco F.R., Di Luca M., Calabresi P. Effects of central and peripheral inflammation on hippocampal synaptic plasticity. Neurobiol. Dis. 2013, 52:229-236.
19. Erickson M.A., Banks W.A. Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis. Brain Behav. Immun. 2011, 25:1637-1648.
20. Fester L., Labitzke J., Hinz R., Behem C., Horling K., Bernhard T., Bader M.I., Vollmer G., Rune G.M. Estradiol responsiveness of synaptopodin in hippocampal neurons is mediated by estrogen receptor beta. J. Steroid Biochem. Mol. Biol. 2013, 138:455-461.
21. Fleige S., Pfaffl M.W. RNA integrity and the effect on the real-time qRT-PCR performance. Mol. Aspects Med. 2006, 27:126-139.
22. Fukazawa Y., Saitoh Y., Ozawa F., Ohta Y., Mizuno K., Inokuchi K. Hippocampal LTP is accompanied by enhanced F-actin content within the dendritic spine that is essential for late LTP maintenance in vivo. Neuron 2003, 38:447-460.
23. Gray E.G. Axo-somatic and axo-dendritic synapses of the cerebral cortex: an electron microscope study. J. Anat. 1959, 93:420-433.
24. Guo W.Z., Miao Y.L., An L.N., Wang X.Y., Pan N.L., Ma Y.Q., Chen H.X., Zhao N., Zhang H., Li Y.F., Mi W.D. Midazolam provides cytoprotective effect during corticosterone-induced damages in rat astrocytes by stimulating steroidogenesis. Neurosci. Lett. 2013, 547:53-58.
25. Holbro N., Grunditz A., Oertner T.G. Differential distribution of endoplasmic reticulum controls metabotropic signaling and plasticity at hippocampal synapses. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:15055-15060.
26. Hulme S.R., Jones O.D., Abraham W.C. Emerging roles of metaplasticity in behaviour and disease. Trends Neurosci. 2013, 36:353-362.
27. Jedlicka P., Schwarzacher S.W., Winkels R., Kienzler F., Frotscher M., Bramham C.R., Schultz C., Bas Orth C., Deller T. Impairment of in vivo theta-burst long-term potentiation and network excitability in the dentate gyrus of synaptopodin-deficient mice lacking the spine apparatus and the cisternal organelle. Hippocampus 2009, 19:130-140.
28. Kohman R.A., Rhodes J.S. Neurogenesis, inflammation and behavior. Brain Behav. Immun. 2013, 27:22-32.
29. Korkotian E., Segal M. Synaptopodin regulates release of calcium from stores in dendritic spines of cultured hippocampal neurons. J. Physiol. 2011, 589:5987-5995.
30. Langguth B., Braun S., Aigner J.M., Landgrebe M., Weinerth J., Hajak G., Eichhammer P. Repetitive transcranial magnetic stimulation in a patient suffering from depression and rheumatoid arthritis: evidence for immunomodulatory effects. Neuro Endocrinol. Lett. 2005, 26:314-316.
31. Maggio N., Segal M. Striking variations in corticosteroid modulation of long-term potentiation along the septotemporal axis of the hippocampus. J. Neurosci. 2007, 27:5757-5765.
32. Maggio N., Segal M. Persistent changes in ability to express long-term potentiation/depression in the rat hippocampus after juvenile/adult stress. Biol. Psychiatry 2011, 69:748-753.
33. Maggio N., Shavit-Stein E., Dori A., Blatt I., Chapman J. Prolonged systemic inflammation persistently modifies synaptic plasticity in the hippocampus: modulation by the stress hormones. Front. Mol. Neurosci. 2013, 6:46.
34. Müller-Dahlhaus F., Vlachos A. Unraveling the cellular and molecular mechanisms of repetitive magnetic stimulation. Front. Mol. Neurosci. 2013, 6:50.
35. Mundel P., Heid H.W., Mundel T.M., Kruger M., Reiser J., Kriz W. Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J. Cell Biol. 1997, 139:193-204.
36. Okada K., Matsunaga K., Yuhi T., Kuroda E., Yamashita U., Tsuji S. The long-term high-frequency repetitive transcranial magnetic stimulation does not induce mRNA expression of inflammatory mediators in the rat central nervous system. Brain Res. 2002, 957:37-41.
37. Okubo-Suzuki R., Okada D., Sekiguchi M., Inokuchi K. Synaptopodin maintains the neural activity-dependent enlargement of dendritic spines in hippocampal neurons. Mol. Cell. Neurosci. 2008, 38:266-276.
38. Osborn M.J., Rosen S.M., Rothfield L., Zeleznick L.D., Horecker B.L. Lipopolysaccharide of the gram-negative cell wall. Science 1964, 145:783-789.
39. Park B.S., Lee J.O. Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp. Mol. Med. 2013, 45:e66.
40. Pribiag H., Stellwagen D. Neuroimmune regulation of homeostatic synaptic plasticity. Neuropharmacology 2014, 78:13-22.
41. Reddy P.H., Mani G., Park B.S., Jacques J., Murdoch G., Whetsell W., Kaye J., Manczak M. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. J. Alzheimers Dis. 2005, 7:103-117. (discussion 173-180).
42. Rothwell J.C. Clinical applications of noninvasive electrical stimulation: problems and potential. Clin. EEG Neurosci. 2012, 43:209-214.
43. Sanchez-Ponce D., Blazquez-Llorca L., DeFelipe J., Garrido J.J., Munoz A. Colocalization of alpha-actinin and synaptopodin in the pyramidal cell axon initial segment. Cereb. Cortex 2012, 22:1648-1661.
44. Santello M., Volterra A. TNFalpha in synaptic function: switching gears. Trends Neurosci. 2012, 35:638-647.
45. Schulz R., Gerloff C., Hummel F.C. Non-invasive brain stimulation in neurological diseases. Neuropharmacology 2013, 64:579-587.
46. Segal M., Vlachos A., Korkotian E. The spine apparatus, synaptopodin, and dendritic spine plasticity. Neuroscientist 2010, 16:125-131.
47. Spacek J. Three-dimensional analysis of dendritic spines. II. Spine apparatus and other cytoplasmic components. Anat. Embryol. 1985, 171:235-243.
48. Sriram K., O'Callaghan J.P. Divergent roles for tumor necrosis factor-alpha in the brain. J. Neuroimmune Pharmacol. 2007, 2:140-153.
49. Steinmetz C.C., Turrigiano G.G. Tumor necrosis factor-alpha signaling maintains the ability of cortical synapses to express synaptic scaling. J. Neurosci. 2010, 30:14685-14690.
50. Stellwagen D., Malenka R.C. Synaptic scaling mediated by glial TNF-alpha. Nature 2006, 440:1054-1059.
51. Tonelli L.H., Postolache T.T. Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge. Neurol. Res. 2005, 27:679-684.
52. Trotta T., Porro C., Calvello R., Panaro M.A. Biological role of Toll-like receptor-4 in the brain. J. Neuroimmunol. 2014, 268:1-12.
53. Vereker E., Campbell V., Roche E., McEntee E., Lynch M.A. Lipopolysaccharide inhibits long term potentiation in the rat dentate gyrus by activating caspase-1. J. Biol. Chem. 2000, 275:26252-26258.
54. Vlachos A. Synaptopodin and the spine apparatus organelle-regulators of different forms of synaptic plasticity?. Ann. Anat. 2012, 194:317-320.
55. Vlachos A., Maggio N., Segal M. Lack of correlation between synaptopodin expression and the ability to induce LTP in the rat dorsal and ventral hippocampus. Hippocampus 2008, 18:1-4.
56. Vlachos A., Korkotian E., Schonfeld E., Copanaki E., Deller T., Segal M. Synaptopodin regulates plasticity of dendritic spines in hippocampal neurons. J. Neurosci. 2009, 29:1017-1033.
57. Vlachos A., Muller-Dahlhaus F., Rosskopp J., Lenz M., Ziemann U., Deller T. Repetitive magnetic stimulation induces functional and structural plasticity of excitatory postsynapses in mouse organotypic hippocampal slice cultures. J. Neurosci. 2012, 32:17514-17523.
58. Vlachos A., Ikenberg B., Lenz M., Becker D., Reifenberg K., Bas-Orth C., Deller T. Synaptopodin regulates denervation-induced homeostatic synaptic plasticity. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:8242-8247.
59. Yamazaki M., Matsuo R., Fukazawa Y., Ozawa F., Inokuchi K. Regulated expression of an actin-associated protein, synaptopodin, during long-term potentiation. J. Neurochem. 2001, 79:192-199.
60. Yang H., Chen C. Cyclooxygenase-2 in synaptic signaling. Curr. Pharm. Des. 2008, 14:1443-1451.
61. Yang X., Song L., Liu Z. The effect of repetitive transcranial magnetic stimulation on a model rat of Parkinson's disease. Neuroreport 2010, 21:268-272.
62. Young G.B. Neurologic complications of systemic critical illness. Neurol. Clin. 1995, 13:645-658.
63. Zhang X.L., Poschel B., Faul C., Upreti C., Stanton P.K., Mundel P. Essential role for synaptopodin in dendritic spine plasticity of the developing hippocampus. J. Neurosci. 2013, 33:12510-12518.
64. Zhang Q.G., Wang R., Tang H., Dong Y., Chan A., Sareddy G.R., Vadlamudi R.K., Brann D.W. Brain-derived estrogen exerts anti-inflammatory and neuroprotective actions in the rat hippocampus. Mol. Cell. Endocrinol. 2014, 10.1016/j.mce.2013.12.019.